科森科技拟9.15亿元出售科森医疗100%股权，外资接盘

Core Viewpoint - Kosen Technology announced the sale of its wholly-owned subsidiary, Kosen Medical, to Jiangsu Yaolingke Medical Technology Co., Ltd. for 915 million yuan, aiming to optimize its asset structure and focus on core business and emerging industries [2][3]. Group 1: Transaction Details - The transaction involves the sale of 100% equity of Kosen Medical, which was established in July 2018 with a registered capital of 118 million yuan, primarily engaged in the processing and export of minimally invasive surgical instruments [2]. - The buyer, Yaolingke, is a wholly-owned subsidiary of FSP, established specifically for this acquisition, with a registered capital of 64.55 million USD and a focus on medical device sales and technology import/export [3]. - The transaction price of 915 million yuan is based on an asset valuation report from Jinzheng (Shanghai) Asset Appraisal Co., Ltd., which estimated Kosen Medical's total equity at 913 million yuan, reflecting a 206.45% appreciation [4]. Group 2: Financial Performance of Kosen Medical - As of September 30, 2025, Kosen Medical reported total assets of 443 million yuan and net assets of 298 million yuan, with revenue of 354 million yuan and net profit of 47.24 million yuan for the first nine months of 2025 [3]. - For the fiscal year 2024, Kosen Medical's projected revenue is 366 million yuan, with a net profit of 41.12 million yuan [3]. Group 3: Transaction Conditions - Yaolingke is required to pay a 1 million USD earnest money within 10 working days after signing the agreement, which will be fully refunded later [4]. - The payment structure includes a 50% initial payment within 15 working days after meeting closing conditions, followed by the remaining 50% after completing business registration changes [4]. - Kosen Medical must maintain normal operations during the transition period and cannot undertake significant capital expenditures or asset disposals without written consent from Yaolingke [4].